CANbridge Pharmaceuticals Appoints General Manager of China

Dec 22, 2020

CANbridge Pharmaceuticals CAN106 Investigational New Drug Application Approved in Singapore for the Treatment of Complement Dysregulation Diseases

Dec 18, 2020

CANbridge Pharmaceuticals Completes $43 Million Series E Financing

Dec 02, 2020

CANbridge Pharmaceuticals Appoints Head of Global Research

Oct 27, 2020

CANbridge Pharmaceuticals Receives Chinese Marketing Approval for Hunterase® First Enzyme Replacement Therapy for Hunter Syndrome in China

Sep 10, 2020

CANbridge Pharmaceuticals Enters into Second Rare Disease Gene Therapy Research Agreement with UMass Medical School

Sep 09, 2020

CANbridge Pharmaceuticals Receives Marketing Approval for Nerlynx® (Neratinib) in Taiwan

Aug 07, 2020

CANbridge Pharmaceuticals Appoints Senior Vice President/Global Head of Business Development

Jun 16, 2020

CANbridge Pharmaceuticals Enters into Rare Disease Gene Therapy Research Agreement with UMass Medical School

Jun 09, 2020